Practice Variation in the Management of Adult Hydroceles: A Multinational Survey.

Journal Information

Full Title: Eur Urol Open Sci

Abbreviation: Eur Urol Open Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 appendix a supplementary data to this article can be found online at https://doi org/10 1016/j euros2023 09 005 ."

Code Sharing
Evidence found in paper:

"

 Financial disclosures: Mikko Forss and Kari A.O. Tikkinen certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: François Hervé received speaker honoraria; is a company consultant for Astellas, Coloplast, Hollister, Medtronic, and Ferring; and received research grants from Astellas. Petrus Järvinen is a shareholder of Osgenic. Mikko Forss, Kostiantyn Bolsunovskyi, Yung Lee, Tuomas P. Kilpeläinen, Yoshitaka Aoki, Sigurdur Gudjonsson, Sachin Malde, Katsuhito Miyazawa, Jukka Sairanen, Lotte Sander, Philippe D. Violette, Lambertus P.W. Witte, Gordon H. Guyatt and Kari A.O. Tikkinen declare no financial conflict of interest. Financial disclosures :"

Evidence found in paper:

"

Financial disclosures: Mikko Forss and Kari A.O. Tikkinen certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: François Hervé received speaker honoraria; is a company consultant for Astellas, Coloplast, Hollister, Medtronic, and Ferring; and received research grants from Astellas. Petrus Järvinen is a shareholder of Osgenic. Mikko Forss, Kostiantyn Bolsunovskyi, Yung Lee, Tuomas P. Kilpeläinen, Yoshitaka Aoki, Sigurdur Gudjonsson, Sachin Malde, Katsuhito Miyazawa, Jukka Sairanen, Lotte Sander, Philippe D. Violette, Lambertus P.W. Witte, Gordon H. Guyatt and Kari A.O. Tikkinen declare no financial conflict of interest. 

Funding/Support and role of the sponsor: This work was supported by the Competitive Research Funding of the Helsinki University Hospital (TYH2020248; TYH2022330) and Sigrid Jusélius Foundation. Open access funded by Helsinki University Library. The sponsors had no role in the analysis and interpretation of the data or the manuscript preparation, review, or approval."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025